Hematologic Oncology Update cover image

Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a 4-Part Series

Hematologic Oncology Update

00:00

Is It OK to Use Bellantimab?

Bellantimab, Afodoten and Mel Flufan have been pulled off the market. Bellamaph can certainly be used because it is an ADC. So I'm not holding my breath for Melflufen, but Bellamaph, though, I do think there is a potential chance of it coming back.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app